Related Experiment Video
Updated: Jul 16, 2026

Isolation and Cannulation of Cerebral Parenchymal Arterioles
Published on: May 23, 2016
The cerebral vasculopathy of Fabry disease
David F Moore1, Christine R Kaneski, Hasan Askari
1Section of Neurology, University of Manitoba, Room GF543, 820 Sherbrook Street, Winnipeg, Manitoba, Canada R3C 4J5.
Insights
Fabry disease, an X-linked disorder, increases stroke risk in individuals under 55. Cerebral vasculopathy involves ischemic strokes, with pathogenesis linked to endothelial dysfunction and a prothrombotic state.
Area of Science:
- Neurology
- Genetics
- Vascular Biology
Background:
- Fabry disease is an X-linked disorder affecting males and females.
- It presents an elevated risk of stroke in patients under 55, with cerebral vasculopathy involving large and small vessels.
- Neuronal glycosphingolipid accumulation may contribute to mild cognitive issues.
Purpose of the Study:
- To elucidate the pathogenesis of Fabry disease-associated cerebral vasculopathy.
- To understand the role of endothelial dysfunction, cerebral hyper-perfusion, and prothrombotic states.
- To explore the influence of genetic and vascular risk factors.
Main Methods:
- Review of existing literature on Fabry disease and cerebral vasculopathy.
- Analysis of proposed pathogenetic mechanisms including endothelial dysfunction and oxidative stress.
- Examination of the role of glycosphingolipids in vascular health.
Main Results:
- The pathogenesis involves abnormal vessel control due to endothelial dysfunction, cerebral hyper-perfusion, and a prothrombotic state.
- Increased reactive oxygen species production is implicated.
- Genetic and vascular risk factors modify these abnormalities.
Conclusions:
- Fabry vasculopathy pathogenesis is complex, involving multiple vascular factors.
- Glycolipids play a role in this and potentially other cerebral vasculopathies.
- Preventive therapy includes anti-platelet agents like clopidogrel.
Abstract:
Fabry disease is an X-linked disorder affecting both males and females. It is associated with an increased risk of stroke in up to 4% of patients below 55 years of age in the general population. The cerebral vasculopathy consists of ischemic strokes involving large and small vessels. The neuronal accumulation of glycosphingolipids appears to have no clinical effect on the natural history of Fabry disease with the possible exception of some reported mild cognitive abnormalities. The pathogenesis of Fabry vasculopathy remains poorly understood but is associated with abnormal functional control of the vessel secondary to endothelial dysfunction, cerebral hyper-perfusion and a prothrombotic state with likely increased production of reactive oxygen species. These abnormalities are further modified by genetic and possibly other vascular risk factors. This vasculopathy illustrates the role of glycolipids in this and possibly other types of cerebral vasculopathies. Therapy is preventive relying on standard medical care and in particular on anti-platelet agents such as clopidogrel.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema l: Introduction
Dementia l: Introduction
Lysosomal Hydrolases
Ischemic Stroke ll: Pathophysiology

